DAFNA Capital Management
-
Aprea Therapeutics Secures Up to $34 Million in Groundbreaking Financing Deal
Doylestown-based Aprea Therapeutics, a leader in precision oncology, has successfully secured a financing deal anticipated to bring in up to $34 million in proceeds, writes…
Founding Partners
Advertisement
Affiliate Partners
